E-ISSN: 1308-5263
Lenalidomide Combined with Interferon α-1b and Interleukin-2 in the Treatment of 21 Cases of Acute Myeloid Leukemia [Turk J Hematol]
Turk J Hematol. 2021; 38(3): 230-232 | DOI: 10.4274/tjh.galenos.2021.2021.0050  

Lenalidomide Combined with Interferon α-1b and Interleukin-2 in the Treatment of 21 Cases of Acute Myeloid Leukemia

Cheng Cheng, Ruihua Mi, Dongbei Li, Lin Chen, Xudong Wei
Affiliated Tumor Hospital of Zhengzhou University, Henan Cancer Hospital, Department of Hematology, Zhengzhou, China

Keywords: Acute myeloid leukemia, Refractory/relapsed, Minimal residual disease, Lenalidomide, Interferon α, -1b, Interleukin-2


Yirmi Bir Akut Myeloid Lösemi Olgusunda İnterferon α-1b ve Interlökin-2 ile Birlikte Lenalidomid Tedavisi

Cheng Cheng, Ruihua Mi, Dongbei Li, Lin Chen, Xudong Wei
Affiliated Tumor Hospital of Zhengzhou University, Henan Cancer Hospital, Department of Hematology, Zhengzhou, China

Anahtar Kelimeler: Akut myeloid lösemi, Dirençli/nüks, Minimal kalıntı hastalık, Lenalidomid, İnterferon α, -1b, İnterlökin-2


Cheng Cheng, Ruihua Mi, Dongbei Li, Lin Chen, Xudong Wei. Lenalidomide Combined with Interferon α-1b and Interleukin-2 in the Treatment of 21 Cases of Acute Myeloid Leukemia. Turk J Hematol. 2021; 38(3): 230-232

Corresponding Author: Xudong Wei, China


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar


 



Impact Factor (2020) = 1.831